Cooper Companies, Inc. (COO) stock
COONasdaqOphthalmic GoodsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 16/3037% below fair value
$62.65+0.46 (+0.74%)
Close on Nov 13, 2026Market cap $11.91BP/E 21.4Yield –
Cooper Companies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cooper Companies's ebitda for the twelve months ending Jul 31, 2026 was $928.20M, down 16.4% year over year. For fiscal 2025 it was $1.06B, down 1.9% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $1.08B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.06B | -1.9% |
| FY2024 | Oct 31, 2024 | $1.08B | +20.0% |
| FY2023 | Oct 31, 2023 | $900.80M | +5.5% |
| FY2022 | Oct 31, 2022 | $853.70M | +4.7% |
| FY2021 | Oct 31, 2021 | $815.10M | -1.5% |
| FY2019 | Oct 31, 2019 | $827.50M | +22.0% |
| FY2018 | Oct 31, 2018 | $678.20M | +9.8% |
| FY2017 | Oct 31, 2017 | $617.50M | +18.2% |
| FY2016 | Oct 31, 2016 | $522.40M | +22.0% |
| FY2015 | Oct 31, 2015 | $428.10M | -3.7% |
| FY2014 | Oct 31, 2014 | $444.69M | +3.1% |
| FY2013 | Oct 31, 2013 | $431.29M | +9.3% |
| FY2012 | Oct 31, 2012 | $394.61M | +21.2% |
| FY2011 | Oct 31, 2011 | $325.71M | +14.7% |
| FY2010 | Oct 31, 2010 | $283.91M | +17.1% |
| FY2009 | Oct 31, 2009 | $242.46M | +15.9% |
| FY2008 | Oct 31, 2008 | $209.15M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $316.70M | +16.8% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $64.40M | -76.8% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $308.30M | +12.9% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $238.80M | -17.5% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $271.10M | -3.7% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $277.40M | +6.7% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $273.00M | +9.2% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $289.40M | +26.7% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $281.50M | +14.4% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $260.00M | +39.0% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $249.90M | +4.5% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $228.40M | +18.6% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $246.10M | +10.7% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $187.10M | -17.2% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $239.20M | +12.4% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $192.50M | -6.5% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $222.30M | +23.8% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $226.10M | +2.4% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $212.80M | +1.9% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $205.90M | +44.4% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $179.50M | +84.3% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $220.70M | +21.5% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $208.90M | -3.8% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $142.60M | -33.0% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $97.40M | -55.2% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $181.70M | +1.1% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $217.20M | +12.4% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $212.90M | +15.3% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $217.60M | +51.4% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $179.70M | +14.6% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $193.20M | +24.1% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $184.60M | +15.4% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $143.70M | -12.0% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $156.80M | +13.2% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $155.70M | +28.0% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $160.00M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $163.30M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $138.50M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $121.60M | – |
See a number that looks wrong?